4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001140361-21-022781
Corporate Controller acquired 53 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Lorenzo Pierre Corporate Controller | 2021-06-25 | Grant or award | +53 | 53 | D | ||
| Derivatives | |||||||
| Lorenzo Pierre Corporate Controller | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +4,830 | 4,830 | D | ||
| Lorenzo Pierre Corporate Controller | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +1,234 | 1,234 | D | ||
| Lorenzo Pierre Corporate Controller | 2021-06-25 | Grant or award · Stock Option (Right to Buy) | +48,535 | 48,535 | D | ||
Loading xslF345X03/form4.xml…